K. Lisspers (Uppsala, Sweden), M. Thomas (Southampton, United Kingdom), D. Ryan (Loughborough, United Kingdom), M. Roman Rodriguez (Soller (Baleares), Spain)
Patients’ opinion for their inhalation device. An assessment of convenience and use
K. Papataxiarchou, K. Athanassiou (Pikermi, Greece)
|  |
Real world effectiveness of changing combination therapy in primary care asthma management
D. Price, I. Small, J. Haughney, D. Ryan, K. Gruffydd-Jones, F. Lavorini, T. Harris, A. Burden, V. Thomas, J. von Ziegenweidt, A. Papi (Aberdeen, Cambridge, Peterhead, Loughborough, Wiltshire, Uxbridge, United Kingdom; Florence, Ferrara, Italy)
|  |
Impact of age on extra-fine particle hydrofluoroalkane beclometasone dipropionate versus fluticasone propionate outcomes in asthmatic children
W. van Aalderen, D. Price, G. Colice, P. Dorinsky, E. Israel, R. Martin, D. Postma, N. Roche, A. Burden, E. Hillyer, C. Hutton, J. von Ziegenweidt, J. Grigg (Amsterdam, Groningen, Netherlands; Aberdeen, Cambridge, London, United Kingdom; Washington, Morrisville, Boston, Denver, United States Of America; Paris, France)
| |
Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy
E. Israel, G. Colice, J. Grigg, R. Martin, W. van Aalderen, P. Dorinsky, D. Postma, N. Roche, A. Burden, J. von Ziegenweidt, F. Barion, E. Hillyer, V. Thomas, D. Price (Boston, Washington, Denver, Morrisville, United States Of America; London, Cambridge, Aberdeen, United Kingdom; Amsterdam, Groningen, Netherlands; Paris, France)
| |
Comparative effectiveness analysis: Extra-fine particle hydrofluoroalkane beclomethasone dipropionate vs fluticasone propionate with spacer in children
J. Grigg, W. van Aalderen, E. Israel, G. Colice, R. Martin, P. Dorinsky, D. Postma, N. Roche, A. Burden, E. Hillyer, C. Hutton, J. von Ziegenweidt, D. Price (London, Cambridge, Aberdeen, United Kingdom; Amsterdam, Groningen, Netherlands; Boston, Washington, Denver, Morrisville, United States Of America; Paris, France)
| |
How well can we practically apply asthma guidelines?
A. Kaplan, N. Griller, L. P. Boulet, S. Gupta (Toronto, Sainte-Foy, Canada)
| |
In whom should regular asthma controller therapy be initiated?
A. Kaplan, N. Grillo, L. P. Boulet, S. Gupta (Toronto, Sainte-Foy, Canada)
| |
Trends in diagnosis and long-term treatment of patients with asthma in primary health care facilities (1998-2011) in Saint-Petersburg, Russia
A. Emelyanov, I. Tsukanova, G. Fedoseev, G. Sergeeva, N. Lisitsyna, L. Bakanina, E. Nikitina (Saint-Petersburg, Russian Federation)
| |
Can young children learn and follow the instructions relating to a new pMDI training device?
M. Levy, M. Sanders, A. Rodman, R. Featherstone (Edinburgh, Harlow, Warwick, Cambridge, United Kingdom)
| |
Exacerbations and symptoms remain common in patients with asthma control: A survey of 8000 patients in Europe
D. Price, T. van de Molen, M. Fletcher (Aberdeen, Warwick, United Kingdom; Groningen, Netherlands)
| |
Innovative dry powder inhaler (DPI) shows improved cost-effectiveness compared with current DPIs for asthma therapy in UK primary care
V. Thomas, A. Burden, J. von Ziegenweidt, S. Gould, C. Hutton, D. Price (Oackington, Aberdeen, United Kingdom)
| |
Evidence-based asthma indicators for primary care using RAND method
M. Praena-Crespo, J. Ruiz-Canela, N. Aquino, J. Sanchez-Diaz, M. Garcia-Gestoso (Sevilla, Spain)
| |
Availability and compliance to basic therapy of bronchial asthma in rural region of Kazakhstan
T. Nurpeissov, T. Nurpeissov, G. Abdushukurova, T. Nurpeissov, A. Zhaksylykova (Almaty, Issyk, Kazakhstan)
| |
Real-life asthma impairment: SABA use depends on smoking phenotype
R. Martin, D. Price, A. McIvor, G. Wong, J. Krishnan, J. D. Campbell, L. Bjermer, M. Miravitlles, A. Chisholm, A. Burden (Barcelona, Spain; Hamilton, Canada; Hong Kong, Hong Kong; Chicago, Denver, United States Of America; Lund, Sweden; Aberdeen, Cambridge, United Kingdom)
| |
Are acute asthma admissions preventable with improved patient education?
L. Mohan Das, J. Murray, M. Ajmal, N. Wolstenholme, A. Jayaratnam (Ilford, United Kingdom)
| |
The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics
J. Pilcher, M. Patel, A. Smith, C. Davies, J. Travers, M. Weatherall, R. Beasley, M. Harwood (Wellington, Lower Hutt, New Zealand; Nottingham, United Kingdom)
| |
Determinants of non-adherence to pharmacologic allergic rhinitis treatment
S. Baldacci, S. Maio, A. Angino, G. Sarno, S. Cerrai, M. Simoni, P. Silvi, F. Di Pede, A. P. Pala, M. Bresciani, G. Viegi (Pisa, Palermo, Italy)
| |
Comparing three different forms of interprofessional education on health professional inhaler technique and maintenance of correct technique
S. Bosnic-Anticevich, M. Williamson, B. Cvetkovski, S. Mavritsakis, P. Travsers-Mason, G. Mendrela, E. Sainsbury, M. Stuart, J. Mackson, C. Armour (Sydney, Australia)
| |
Medical doctors’ knowledge, attitudes and practice patterns in asthma’s diagnosis and management in Vietnam
P. Thu Phuong, N. Quy Chau, N. Thanh Hoi, V. Van Giap, C. Thi Hanh (Hanoi, Viet Nam)
| |